Benzinga | Mar 4, 2021 09:19AM EST

BioSig Awarded U.S. Patent Claims for its NeuroClear Subsidiary

* The patent is exclusively licensed from Mayo Foundation for Medical Education and Research

* Claims address methods and materials for improving the treatment of hypertension

* Fifteen additional licensed worldwide patent applications are pending, generally covering electroporation and stimulation